Skip Nav Destination
1-20 of 44
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Martin W. Schoen, MDMPH, Peter Georgantopoulos, MS, Nagasai S Yalavarthi, BS, Charles L. Bennett, MD PhD
Blood (2019) 134 (Supplement_1): 2135.
Venetoclax in Combination with High-Dose Chemotherapy Is Active and Well-Tolerated in Children with Relapsed or Refractory Acute Myeloid Leukemia
Seth E Karol, MD, Thomas Alexander, MDMPH, Amit Budraja, PhD, Stanley Pounds, PhD, Kristin E Canavera, PhD, Lei Wang, MS, Joshua Wolf, MBBS, PhD, Jeffery M. Klco, MD PhD, Ahmed Hamed Salem, PhD FCP, Tammy Palenski, PhD, Norman J. Lacayo, MD, Ching-Hon Pui, MD, Joseph T. Opferman, PhD, Jeffrey Rubnitz, MD PhD
Blood (2019) 134 (Supplement_1): 178.
Incidence of Invasive Fungal Infections in Acute Leukemia Patients Utilizing Micafungin Prophylaxis Compared to Second-Generation Azole Prophylaxis
Heather Morris, PharmD, BCPS, Meredith T. Moorman, PharmD, BCOP, CPP, Melissa C. Mackey, PharmD, BCPS, BCOP, Harry P. Erba, MD PhD, Thomas W. LeBlanc, MDMA,MHS, David A. Rizzieri, MD, Ian Barak, MS, Zhiguo Li, PhD, Tanya Zapolskaya, PharmD, BCPS, BCOP
Blood (2019) 134 (Supplement_1): 5105.
Invasive Fungal Disease Following Myeloablative Cord Blood Transplantation for Patients with Hematological Malignancies
Duihong Li, Huang Jiafu, Xiaofan Li, MD PhD, Zheng Jing, Haiying Fu, Zhenshu Xu, MD, Yuanzhong Chen, MD PhD, Nainong LI
Blood (2019) 134 (Supplement_1): 5653.
Midostaurin in Combination with Idarubicin and Cytarabine (3+7) Induction for FLT3 Positive AML - Very High Complete Response Rates and Transition to Allogeneic Transplantation
Jacques Azzi, MD, Frank Cirrone, PharmD, Maher Abdul Hay, MD, David Kaminetzky, MD, Kenneth B. Hymes, MD, Maxim Kreditor, MD, Ahmad-Samer Al-Homsi, MD, Michael L. Grossbard, MD, Catherine Diefenbach, MD, Tibor Moskovits, MD, Shella Saint Fleur-Lominy, MD PhD, Bruce G. Raphael, MD, Raoul Tibes, MD PhD
Blood (2018) 132 (Supplement 1): 5216.
Classical Empiric Antifungal Therapy Vs. D-Index Guided Early Therapy Using Micafungin for Persistent Febrile Neutropenia (CEDMIC trial): A Randomized Controlled Trial from Japan FN Study Group
Shun-Ichi Kimura, MD PhD, Yoshinobu Kanda, MD PhD, Masaki Iino, MD PhD, Takahiro Fukuda, MD PhD, Emiko Sakaida, MD PhD, Tatsuo Oyake, Hiroki Yamaguchi, MD PhD, Shin-ichiro Fujiwara, MD PhD, Junji Suzumiya, MD PhD, Akinao Okamoto, MD PhD, Hiroyuki Fujita, MD PhD, Yasushi Takamatsu, MD PhD, Yoshio Saburi, MD PhD, Jun Yamanouchi, MD PhD, Itaru Matsumura, MD, Souichi Shiratori, Moritaka Gotoh, MD PhD, Shingen Nakamura, MD PhD, Kazuo Tamura, MD PhD
Blood (2018) 132 (Supplement 1): 816.
Invasive Fungal Infection in the Setting of Peripheral Blood Non-Manipulated Haploidentical Stem Cell Transplantation with Postransplant Cyclophosphamide
Nieves Dorado, MD, Gillen Oarbeascoa, MD, Miguel Argüello, MD, Pascual Balsalobre, PhD, David Serrano, MD, Carolina Martínez-Laperche, Rebeca Bailén, MD, Javier Anguita, MD PhD, Jose Luis Díez-Martín, MD PhD, Mi Kwon
Blood (2018) 132 (Supplement 1): 5710.
Retrospective Analysis of Adults with Acute Myeloid Leukemia Treated with Venetoclax Plus Hypomethylating Agents at a Comprehensive Cancer Center
Blood (2018) 132 (Supplement 1): 1424.
Hyunkyung Park, MD, Youk Jeonghwan, Wan Beom Park, MD PhD, Dong-Yeop Shin, MDPhD, Junshik Hong, MD, Inho Kim, MD PhD, Kim Nam Joong, Hyun Jung Lee, MD, Hyo Jung Kim, MD PhD, Sung-Soo Yoon, MD PhD, Youngil Koh, MD
Blood (2017) 130 (Supplement 1): 5033.
Feasibility and Outcome of Late Intensification with Native L-Asparaginase for Acute Lymphoblastic Leukemia in the Elderly: A Single Center Experience
Francois Xavier Gros, MD, Pierre-Yves Dumas, MD, Edouard Forcade, MD, Claire Calmettes, MD, Margot Robles, MD, Vincent Servant, PharmD, Nicolas Lechevalier, PharmD, Audrey Bidet, PharmD, Noel Milpied, Arnaud Pigneux, MD PhD, Thibaut Leguay, MD
Blood (2017) 130 (Supplement 1): 1296.
"Mucormycosis" the Emerging Global Threat; Overview and Treatment Outcome Among Pediatric Cancer Patients in Egypt
Yousef Madney, MD, Reham Khedr, MD, Hadir Al-Mahellawy, MD, Naglaa Adel, Msc, Hala Taha, MD, Iman Zaki, MD, Ayda Youssef, MD, Gehad Taha, MD, Omaima Hassanain, Hanafy Hafez, MD
Blood (2017) 130 (Supplement 1): 4830.
Comparison of Micafungin and Liposomal Amphotericin B for Empirical Antifungal Therapy in Febrile Neutropenic Patients with Acute Myeloid Leukemia: A Randomized Controlled Trial
Tatsuo Oyake, MD, PhD, Yuka Fujisawa, MD, PhD, Norifumi Sugawara, MD, PhD, Ryousei Sasaki, MD, PhD, Wataru Izumita, MD, Takahiro Mine, MD, Maki Asahi, MD, PhD, Yuzo Suzuki, MD, PhD, Yoshiaki Okano, MD, Yukiteru Fujishima, MD, Yasuhiko Tsukushi, MD, PhD, Yusei Aoki, MD, Shugo Kowata, MD, PhD, Ichiro Hanamura, MD, PhD, Kazunori Murai, MD, PhD, Shigeki Ito, MD, PhD, Yoji Ishida, MD, PhD
Blood (2016) 128 (22): 1607.
CYP2C19 Genotype-Guided Dosing and Voriconazole Concentrations in Hematopoietic Stem Cell Transplant Patients (HSCT) Receiving Antifungal Prophylaxis
Jai N Patel, PharmD, Myra M Robinson, Issam Hamadeh, PharmD, Zainab Shahid, MD, James T Symanowski, PhD, Dragos Plesca, PharmD, PhD, Margaret Croom, PharmD, Jigar Trivedi, MSc, PharmD, Nury M. Steuerwald, PhD, Belinda R. Avalos, MD, Edward A. Copelan, MD FACP
Blood (2016) 128 (22): 3416.
Micafungin As Antifungal Prophylaxis during Induction Phase of Chemotherapy in Pediatric Acute Lymphoblastic Leukemia
Sahar A Khalil, MD, Afaf m Mahmoud, MSc, Lobna m Shalaby, MD, Hadir A el-Mahallawy, MD, Alaa M Elhaddad, MD PhD
Blood (2016) 128 (22): 5152.
Randomized Trial of Micafungin Versus Fluconazole in Prophylaxis Against Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients
Silvia Park, MD, Kihyun Kim, Jun Ho Jang, MD PhD, Seok Jin Kim, MDPhD, Won Seog Kim, MD PhD, Chul Won Jung, MD PhD, Ki Sun Jung, Jinhyun Cho, Kwai Han Yoo, MD, Haa-na Song
Blood (2015) 126 (23): 1904.
Efficacy and Safety of Micafungin As Salvage Treatment for Invasive Fungal Disease in Patients with Hematologic Malignancies
Blood (2015) 126 (23): 4628.
Efficacy and Cost-Effectiveness of a Different Schedule for the Prevention of Fungal Infections during the Early Phase of Stem Cell Transplantation
Lucrecia Yáñez, MD, Noemí Fernández, MD, Arancha Bermudez, MD, Germán Pérez, MD, Andres Insunza, MD, Carlos Richard, MD, Eulogio Conde, MD PhD
Blood (2014) 124 (21): 1154.
A Phase I/II Trial Evaluating the Use of a Histone Deacetylase Inhibitor Panobinostat (LBH589) in Addition to Glucocorticoids in Patients with Acute Graft-Versus-Host Disease
Lia Perez, MD, Teresa Field, MD PhD, Marcie L Riches, MD MS, Hugo F Fernandez, MD, Frederick L Locke, MD, Brian C Betts, MD, Joseph Pidala, MD PhD, Erika Elmer, CCRP, Francisca Beato, BS, Maritza Lienlaf, MS, Pedro Horna, MD, Alejandro Villagra, PhD, Claudio Anasetti, MD
Blood (2014) 124 (21): 1167.
Invasive Candida Infections in Pediatric Patients Treated on the Pilot Study of Decitabine and Vorinostat with Chemotherapy for Relapsed ALL: A Report from the Therapeutic Advances in Childhood Leukemia & Lymphoma (TACL) Consortium
Michael J. Burke, MD, Patrick Brown, MD, Lia Gore, MD, Richard Sposto, PhD, Deepa Bhojwani, Bill H Chang, MD PhD, Steven G. Dubois, MD, Paul S Gaynon, MD, Julia Glade-Bender, MD, Kenneth Matthew Heym, MD, Maria Luisa Sulis, MD, Jessica A. Pollard, MD, Anupam Verma, MD, Van Huynh, MD
Blood (2014) 124 (21): 3650.
a Randomized, Controlled, Prospective Study for Efficacy of Micafungin Versus Itraconazole As Empirical Antifungal Therapy for Febrile Neutropenic Patients with Acute Leukemia
Seong Hyun Jeong, MD, Dae Young Kim, Jun Ho Jang, Yeung-Chul Mun, Sung-Hyun Kim, Chul Won Choi, Jin Seok Kim, Joon Seong Park, MD
Blood (2014) 124 (21): 3729.